PMC:7103735 / 34760-35502
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T359 | 183-191 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T360 | 183-187 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T361 | 388-396 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T362 | 388-392 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T363 | 445-454 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T364 | 642-650 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T365 | 642-646 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T404 | 324-325 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T405 | 466-473 | http://purl.obolibrary.org/obo/NCBITaxon_9443 | denotes | primate |
| T406 | 530-531 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T407 | 579-580 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T95 | 28-36 | Chemical | denotes | carriers | http://purl.obolibrary.org/obo/CHEBI_78059 |
| T96 | 59-68 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T97 | 669-677 | Chemical | denotes | carriers | http://purl.obolibrary.org/obo/CHEBI_78059 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T32 | 117-132 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
| T33 | 364-379 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
| T34 | 417-434 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T35 | 417-434 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T297 | 0-107 | Sentence | denotes | Theoretically, asymptomatic carriers might arise when host antiviral defence is either strong or decoupled. |
| T298 | 108-241 | Sentence | denotes | When the immune response effectively limits but could not completely block SARS-CoV-2 replication, asymptomatic shedding might occur. |
| T299 | 242-341 | Sentence | denotes | In this scenario, the risk of transmitting to others is relatively low because of a low viral load. |
| T300 | 342-578 | Sentence | denotes | Alternatively, if the immune response against SARS-CoV-2 is decoupled from viral replication as in the infection of natural primate hosts with SIVs, the viral load would be higher, posing a higher risk for person-to-person transmission. |
| T301 | 579-742 | Sentence | denotes | A careful quantitative analysis of the replication dynamics of SARS-CoV-2 in asymptomatic carriers over time is required to clarify the validity of the two models. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1035 | 183-193 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1036 | 388-398 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1037 | 642-652 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1038 | 485-489 | Species | denotes | SIVs | Tax:11723 |
| 1039 | 445-454 | Disease | denotes | infection | MESH:D007239 |